Arkolith/Insider Trading/ETON/Form 4

Gruber James R.

Chief Financial OfficerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Aug 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$674K
Net Open-Market Flow
-$674K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2025Sell(S)3K$16.02$42K205K
Aug 19, 2025Sell(S)39K$16.16$632K205K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-027464) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML